XML 29 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Statements of Cash Flows (unaudited) - USD ($)
9 Months Ended
Sep. 29, 2015
Sep. 30, 2014
Cash flows from operations:    
Net income $ 106,182,000 $ 130,801,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 100,167,000 90,681,000
Stock-based compensation expense 11,110,000 8,032,000
Tax benefit from stock-based compensation (2,023,000) (2,733,000)
Deferred income taxes (34,908,000) (12,410,000)
Refranchising loss, cash flow 10,786,000 0
Other 1,928,000 1,434,000
Changes in operating assets and liabilities, excluding the effect of acquisitions and dispositions:    
Trade and other accounts receivable, net 33,128,000 17,924,000
Inventories 682,000 1,486,000
Prepaid expenses and other (11,762,000) (7,121,000)
Deposits and other (179,000) 237,000
Accounts payable 3,723,000 3,100,000
Accrued expenses (39,089,000) (35,349,000)
Deferred rent 2,433,000 (282,000)
Other long-term liabilities (5,669,000) (1,162,000)
Net cash provided by operating activities 176,509,000 194,638,000
Cash flows from investing activities:    
Additions to property and equipment (153,301,000) (155,348,000)
Proceeds from refranchising 20,805,000 0
Proceeds from sale-leaseback transactions 10,095,000 10,315,000
Proceeds from sale of property and equipment 1,553,000 0
Net cash used in investing activities (120,848,000) (145,033,000)
Cash flows from financing activities:    
Proceeds from Issuance of Long-term Debt 299,070,000 100,000,000
Capitalized debt issuance costs (363,000) (193,000)
Payment of Deferred Acquisition Holdback 0 (270,000)
Repurchase of common stock (280,301,000) (134,247,000)
Exercise of employee stock options 0 863,000
Tax benefit from stock-based compensation 2,023,000 2,733,000
Proceeds from issuance of common stock under employee benefit plans 2,594,000 2,374,000
Net cash used in financing activities 23,023,000 (28,740,000)
Net (decrease) increase in cash and cash equivalents 78,684,000 20,865,000
Cash and cash equivalents at beginning of period 196,493,000 125,245,000
Cash and cash equivalents at end of period $ 275,177,000 $ 146,110,000